Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation

Molecular Carcinogenesis

Volumn 19, Issue 4, 1997, Pages 221-224

  Woloschak, Michael ^a   Yu, Aiqin ^a   Post, Kalmon D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gene methylation; Human pituitary tumor; p16

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; PROTEIN P16; THYROTROPIN;

ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; GENE ACTIVATION; GENE FREQUENCY; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS TUMOR; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

ADENOMA; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION;

RODENTIA;

EID: 0030801289     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199708)19:4<221::AID-MC1>3.0.CO;2-F     Document Type: Article

References (19)

1. Lee EY-HP, Chang CY, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-295,1992.
2. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 359:295-300, 1992.
3. Clarke AR, Maandag ER, Van Roon M, et al. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330, 1992.
4. Woloschak MW, Roberts JL, Post KD. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer 74:693-696, 1994.
5. Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77:644-646, 1993.
6. Woloschak M, Yu A, Xiao J, Post KD. Abundance and state of phosphorylation of the Rb gene product in human pituitary tumors. Int J Cancer 67:16-19, 1996.
7. Woloschak M, Yu A, Xiao J, Post KD. Frequent loss of the p16 gene product in human pituitary tumors. Cancer Res 56:2493-2496, 1996.
8. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDK2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530, 1995.
9. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDK2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531-4535, 1995.
10. Issa JP, Vertino PM, Wu J, et al. Increased cytosine DNAmethyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235-1240, 1993.
11. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13-15, 1995.
12. Farrell WE, Simpson D, Bicknell J, Talbot JA, Bates AS, Clayton RN. Chromosome 9p deletions in Cushing adenoma:An early event in pituitary tumorigenesis (abstract #P3-829). Proceedings of the 10th International Congress of Endocrinology 2:962, 1996.
13. Boggild MD, Jenkinson S, Pistorello M, et al. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 78:387-392, 1994.
14. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55:6200-6209, 1995.
15. Costello JF, Berger MS, Huang H-JS, Cavenee WK. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56:2405-2410, 1996.
16. Lo K-W, Cheung S-T, Leung S-F, et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56:2721-2725, 1996.
17. Koeberl DD, Bottema CDK, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS. Mutations causing hemophilia B:Direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene. Am J Hum Genet 47:202-217, 1990.
18. El-Deiry WS, Nelkin BD, Celano P, et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88:3470-3474, 1991.
19. Ferguson AT, Vertino PM, Davidson NE. Effects of 5-aza-2′deoxycytidine on human breast cancer cell lines with variable DNA methyltransferase activity (abstract #3675). Proceedings of the American Association for Cancer Research 37:537, 1996.